28 related articles for article (PubMed ID: 22995933)
1. Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.
Ruberg SJ; Chen L; Stauffer V; Ascher-Svanum H; Kollack-Walker S; Conley RR; Kane J; Kinon BJ
BMC Psychiatry; 2011 Feb; 11():23. PubMed ID: 21306626
[TBL] [Abstract][Full Text] [Related]
2. Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study.
Millgate E; Griffiths K; Egerton A; Kravariti E; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Oloyede E; Owens R; Pollard R; Rich N; Smart S; Segev A; Verena Sendt K; MacCabe J;
BMJ Open; 2022 Nov; 12(11):e062570. PubMed ID: 36410817
[TBL] [Abstract][Full Text] [Related]
3. New role of platelets in schizophrenia: predicting drug response.
Zhang Y; Zheng Y; Ni P; Liang S; Li X; Yu H; Wei W; Qi X; Yu X; Xue R; Zhao L; Deng W; Wang Q; Guo W; Li T
Gen Psychiatr; 2024; 37(2):e101347. PubMed ID: 38616969
[TBL] [Abstract][Full Text] [Related]
4. Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
Tang Y; Wu Y; Li X; Hao Q; Deng W; Yue W; Yan H; Zhang Y; Tan L; Chen Q; Yang G; Lu T; Wang L; Yang F; Zhang F; Yang J; Li K; Lv L; Tan Q; Zhang H; Ma X; Li L; Wang C; Ma X; Zhang D; Yu H; Zhao L; Ren H; Wang Y; Zhang G; Li C; Du X; Hu X; Li T; Wang Q
Curr Neuropharmacol; 2023; 21(2):424-436. PubMed ID: 36411567
[TBL] [Abstract][Full Text] [Related]
5. Reduced cortical cerebral blood flow in antipsychotic-free first-episode psychosis and relationship to treatment response.
Selvaggi P; Jauhar S; Kotoula V; Pepper F; Veronese M; Santangelo B; Zelaya F; Turkheimer FE; Mehta MA; Howes OD
Psychol Med; 2023 Aug; 53(11):5235-5245. PubMed ID: 36004510
[TBL] [Abstract][Full Text] [Related]
6. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
[TBL] [Abstract][Full Text] [Related]
7. Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".
Japanese Society of Neuropsychopharmacology
Neuropsychopharmacol Rep; 2021 Sep; 41(3):266-324. PubMed ID: 34390232
[No Abstract] [Full Text] [Related]
8. Early Response in Adolescents with Schizophrenia is not Associated with Remission at Six Months.
Arceo S; Ulloa RE
J Can Acad Child Adolesc Psychiatry; 2019 Aug; 28(2):91-93. PubMed ID: 31447907
[TBL] [Abstract][Full Text] [Related]
9. [The CIMH track concept in the treatment of psychotic disorders].
Hirjak D; Gass P; Deuschle M; Leweke FM; Böhringer A; Schenkel N; Borgwedel D; Heser M; Breisacher A; Meyer-Lindenberg A
Nervenarzt; 2020 Mar; 91(3):233-242. PubMed ID: 30976829
[TBL] [Abstract][Full Text] [Related]
10. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
Pan PY; Lee MS; Yeh CB
BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
[TBL] [Abstract][Full Text] [Related]
12. Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia.
Hatta K; Ito H
Clin Psychopharmacol Neurosci; 2014 Apr; 12(1):1-7. PubMed ID: 24851115
[TBL] [Abstract][Full Text] [Related]
13. Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials.
Stauffer V; Case M; Kollack-Walker S; Ascher-Svanum H; Ball T; Kapur S; Kinon BJ
Schizophr Res; 2011 Aug; 130(1-3):11-9. PubMed ID: 21489754
[TBL] [Abstract][Full Text] [Related]
14. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia.
Kinon BJ; Chen L; Ascher-Svanum H; Stauffer VL; Kollack-Walker S; Sniadecki JL; Kane JM
Schizophr Res; 2008 Jul; 102(1-3):230-40. PubMed ID: 18423985
[TBL] [Abstract][Full Text] [Related]
15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
16. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic treatment response in schizophrenia.
Gardner KN; Bostwick JR
Am J Health Syst Pharm; 2012 Nov; 69(21):1872-9. PubMed ID: 23111671
[TBL] [Abstract][Full Text] [Related]
18. Early symptom response to antipsychotic medication as a marker of subsequent symptom change: an eighteen-month follow-up study of recent episode schizophrenia.
Levine SZ; Leucht S
Schizophr Res; 2012 Nov; 141(2-3):168-72. PubMed ID: 22995933
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
